The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain
- PMID: 20182714
- DOI: 10.1007/s00259-010-1383-7
The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain
Abstract
Purpose: Small animal PET can be applied to study molecular processes in animal models of a variety of human diseases. In order to keep the animals in a restricted position during imaging, anaesthesia is in many instances inevitable. Using small animal PET and ex vivo autoradiography, we examined the influence of pentobarbital and isoflurane anaesthesia on the rat brain uptake of [(18)F]MK-9470, a radioligand for the type 1 cannabinoid receptor.
Methods: PET imaging was performed on adult Wistar rats under pentobarbital (n = 6) and isoflurane anaesthesia (n = 7), and under control conditions (free moving during tracer uptake, n = 8). Parametric PET images were generated, anatomically standardized and analysed by voxel-based Statistical Parametric Mapping and a predefined volume of interest approach. Immediately after in vivo PET, brains were processed for ex vivo autoradiography using manually placed regions of interest. An extra group (n = 6) was included ex vivo, in which animals were intravenously injected without the use of anaesthetics.
Results: Using in vivo and ex vivo molecular imaging techniques, no significant changes in absolute [(18)F]MK-9470 uptake were present in the brain of pentobarbital and isoflurane rats as compared to control conditions. Relative [(18)F]MK-9470 uptake PET values obtained applying global scaling were, however, decreased in the cortex under both anaesthetics (pentobarbital: -13.3+/-1.4%; isoflurane -8.7 +/- 3.1%), while an increase was seen in the cerebellum by 13.5 +/- 4.0% and 13.9 +/- 4.1% under pentobarbital and isoflurane, respectively. Ex vivo results were in agreement with in vivo findings.
Conclusion: These findings suggest a similar, regionally specific interference of pentobarbital and isoflurane anaesthesia with in vivo CB1 receptor imaging using [(18)F]MK-9470.
Similar articles
-
Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2354-63. doi: 10.1007/s00259-010-1574-2. Epub 2010 Aug 3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20680268
-
Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.Synapse. 2010 Aug;64(8):617-23. doi: 10.1002/syn.20769. Synapse. 2010. PMID: 20340169
-
Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470.J Mol Neurosci. 2010 Oct;42(2):162-7. doi: 10.1007/s12031-010-9340-2. Epub 2010 Feb 25. J Mol Neurosci. 2010. PMID: 20182818
-
Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain.Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1467-77. doi: 10.1007/s00259-012-2163-3. Epub 2012 Jun 15. Eur J Nucl Med Mol Imaging. 2012. PMID: 22699528
-
Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.Curr Pharm Des. 2008;14(31):3363-83. doi: 10.2174/138161208786549380. Curr Pharm Des. 2008. PMID: 19075713 Review.
Cited by
-
Voxel-based analysis of amyloid-burden measured with [(11)C]PiB PET in a double transgenic mouse model of Alzheimer's disease.Mol Imaging Biol. 2013 Oct;15(5):576-84. doi: 10.1007/s11307-013-0625-z. Mol Imaging Biol. 2013. PMID: 23572425
-
Reproducibility of non-invasive a1 adenosine receptor quantification in the rat brain using [(18)F]CPFPX and positron emission tomography.Mol Imaging Biol. 2014 Oct;16(5):699-709. doi: 10.1007/s11307-014-0729-0. Mol Imaging Biol. 2014. PMID: 24595700
-
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):308-21. doi: 10.1007/s00259-013-2522-8. Epub 2013 Sep 5. Eur J Nucl Med Mol Imaging. 2014. PMID: 24006151
-
Quantification of the Cannabinoid Type 1 Receptor Availability in the Mouse Brain.Front Neuroanat. 2020 Nov 20;14:593793. doi: 10.3389/fnana.2020.593793. eCollection 2020. Front Neuroanat. 2020. PMID: 33328905 Free PMC article.
-
Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2354-63. doi: 10.1007/s00259-010-1574-2. Epub 2010 Aug 3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20680268
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical